Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
ClinicalTrials.gov study NCT01639456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05987696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
ClinicalTrials.gov study NCT00161590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00934986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
ClinicalTrials.gov study NCT01178658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
ClinicalTrials.gov study NCT02805829. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute My
ClinicalTrials.gov study NCT02781467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
ClinicalTrials.gov study NCT00089453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
ClinicalTrials.gov study NCT00374699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)
ClinicalTrials.gov study NCT02961712. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
ClinicalTrials.gov study NCT03634501. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT06751134. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06027853. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
ClinicalTrials.gov study NCT04254419. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03348033. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
ClinicalTrials.gov study NCT06687681. IPD Sharing: NO. Countries: 1. Publications: 0.
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
ClinicalTrials.gov study NCT03420963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00540956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS
ClinicalTrials.gov study NCT03955848. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
ClinicalTrials.gov study NCT05503134. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.